Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Trends in Cancer
|
December 9, 2022
Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies
Deepak Bhamidipati, Vivek Subbiah
Trends in Cancer
|
July 30, 2023
Tumor-agnostic drug development in dMMR/MSI-H solid tumors
Deepak Bhamidipati, Vivek Subbiah
JCO Precision Oncology
|
February 21, 2024
Targeting All <i>BRAF</i> Alterations: The (Re)-Search Continues
Deepak Bhamidipati, Andrew Pellatt, Vivek Subbiah
JCO Oncology Practice
|
May 13, 2024
Ready, Set, Go: Setting Off on the Mission to Target <i>KRAS</i> in Colorectal Cancer
Andrew J Pellatt, Deepak Bhamidipati, Vivek Subbiah
Chinese Clinical Oncology
|
August 27, 2017
Re-irradiation for recurrent glioblastoma multiforme
Christian Barney, Gaurav Shukla, Deepak Bhamidipati, et al.
Journal of Immunotherapy and Precision Oncology
|
January 15, 2025
Durable Remission After Targeted Therapy in <i>BRAF V600E-</i>Mutant Metastatic Colorectal Cancer: Case Report
Daniel A Fox, Deepak Bhamidipati, Scott Kopetz, et al.
British Journal of Cancer
|
July 10, 2023
PARP inhibitors: enhancing efficacy through rational combinations
Deepak Bhamidipati, Jaime I Haro-Silerio, Timothy A Yap, et al.
Journal of Neuro-Oncology
|
February 29, 2020
Outcomes after stereotactic radiosurgery for CNS lymphoma
Joshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
Journal of Radiation Oncology
|
November 13, 2018
Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey
Erik Scott Blomain, Hyun Kim, Shivank Garg, et al.
Journal of Neuro-Oncology
|
August 9, 2018
Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus
Joshua D Palmer, Deepak Bhamidipati, Minesh Mehta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Trends in Cancer
|
December 9, 2022
Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies
Deepak Bhamidipati, Vivek Subbiah
Trends in Cancer
|
July 30, 2023
Tumor-agnostic drug development in dMMR/MSI-H solid tumors
Deepak Bhamidipati, Vivek Subbiah
JCO Precision Oncology
|
February 21, 2024
Targeting All <i>BRAF</i> Alterations: The (Re)-Search Continues
Deepak Bhamidipati, Andrew Pellatt, Vivek Subbiah
JCO Oncology Practice
|
May 13, 2024
Ready, Set, Go: Setting Off on the Mission to Target <i>KRAS</i> in Colorectal Cancer
Andrew J Pellatt, Deepak Bhamidipati, Vivek Subbiah
Chinese Clinical Oncology
|
August 27, 2017
Re-irradiation for recurrent glioblastoma multiforme
Christian Barney, Gaurav Shukla, Deepak Bhamidipati, et al.
Journal of Immunotherapy and Precision Oncology
|
January 15, 2025
Durable Remission After Targeted Therapy in <i>BRAF V600E-</i>Mutant Metastatic Colorectal Cancer: Case Report
Daniel A Fox, Deepak Bhamidipati, Scott Kopetz, et al.
British Journal of Cancer
|
July 10, 2023
PARP inhibitors: enhancing efficacy through rational combinations
Deepak Bhamidipati, Jaime I Haro-Silerio, Timothy A Yap, et al.
Journal of Neuro-Oncology
|
February 29, 2020
Outcomes after stereotactic radiosurgery for CNS lymphoma
Joshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
Journal of Radiation Oncology
|
November 13, 2018
Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey
Erik Scott Blomain, Hyun Kim, Shivank Garg, et al.
Journal of Neuro-Oncology
|
August 9, 2018
Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus
Joshua D Palmer, Deepak Bhamidipati, Minesh Mehta, et al.
Page
of 2